Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:03:31 EDT Sun 26 Mar 2023
Enter Symbol
or Name
USA
CA



News for U:OSA from 2022-03-25 to 2023-03-24 - 21 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2023-03-21 08:00U:OSANews ReleaseProSomnus ‚ ® Receives Patent Allowance Covering Automated Manufacturing Process for Company ¢ € ™s Novel Precision Sleep Apnea Medical Devices
2023-03-16 16:05U:OSANews ReleaseProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
2023-03-10 08:00U:OSANews ReleaseProSomnus ‚ ® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society ¢ € ™s Sleep and Breathing 2023 Conference
2023-03-01 16:05U:OSANews ReleaseProSomnus to Present at Two Upcoming Investor Conferences in March 2023
2023-03-01 08:00U:OSANews ReleaseProSomnus ‚ ® Appoints Brian Dow as Chief Financial Officer
2023-02-01 17:15U:OSANews ReleaseProSomnus ‚ ® Provides Business Update and Preliminary 2022 Revenue Guidance
2023-01-26 08:00U:OSANews ReleaseProSomnus ‚ ® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference
2022-12-21 08:00U:OSANews ReleaseProSomnus ‚ ® Announces Completion of Enrollment in Antwerp University Hospital ¢ € ™s ‚  First Line Obstructive Sleep Apnea Treatment Study (FLOSAT)
2022-12-19 08:00U:OSANews ReleaseProSomnus ‚ ® Enrolls First Participant in Study Evaluating Safety and Efficacy of ProSomnus EVO ¢ „ ¢ in Treating Severe Obstructive Sleep Apnea
2022-12-15 08:00U:OSANews ReleaseProSomnus ‚ ® Announces Medicare Reimbursement for ‚  ProSomnus EVO ‚ ® [PH] Sleep Apnea and Snoring Device
2022-12-08 08:00U:OSANews ReleaseStudy Published in "Military Medicine" Reports 88% Success Treating Obstructive Sleep Apnea Patients with Precision Oral Appliance Therapy
2022-12-06 17:55U:OSANews ReleaseProSomnus ‚ ® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices
2022-12-06 17:55U:LAAANews ReleaseProSomnus ‚ ® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices
2022-12-02 16:05U:LAAANews ReleaseLakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus
2022-11-02 08:30U:LAAANews ReleaseProSomnus(TM) Announces FDA 510(k) Clearance for ProSomnus EVO(TM) [PH] Sleep and Snore Device
2022-10-05 09:00U:LAAANews ReleaseProSomnus(TM) Sleep Technologies to Participate at the Oppenheimer Private Company Showcase
2022-09-15 18:03U:LAAANews ReleaseProSomnus(TM) Announces Availability of Insurance Reimbursement for Oral Appliance Therapy Devices in Germany
2022-08-26 16:30U:LAAANews ReleaseProSomnus(TM) Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes
2022-06-28 08:00U:LAAANews ReleaseProSomnus(TM) to Open New Global Headquarters and Manufacturing Center of Excellence, Increasing Manufacturing Capacity and Efficiency
2022-06-03 08:00U:LAAANews ReleaseProSomnus(TM) to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
2022-05-10 08:00U:LAAANews ReleaseProSomnus(TM), Leader in Patient-Preferred Sleep Apnea Therapy, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition I Corp.